Design
Other
Authors
Loading...
May enable in vivo beta-ray measurements; leaves open clinical validation for hemodynamic and malignancy applications.
The development of the CASRAD probe enables in vivo measurement of beta-ray activity for various clinical applications, including hemodynamic studies and malignancy detection.
Takayanagi et al. (1972) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: